Cargando…

Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population

BACKGROUND: Triple-negative breast cancer (TNBC) represents about 19% of all breast cancer cases in the Chinese population. Lack of targeted therapy contributes to the poorer outcomes compared with other breast cancer subtypes. Comprehensive genomic profiling helps to explore the clinically relevant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Liye, Zhai, Qinglian, Lu, Qianyi, Lee, Kaping, Zheng, Qiufan, Hong, Ruoxi, Wang, Shusen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Medical Genetics & Genomics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381897/ https://www.ncbi.nlm.nih.gov/pubmed/34396843 http://dx.doi.org/10.1080/07853890.2021.1966086

Ejemplares similares

CPSF4 promotes triple negative breast cancer metastasis by upregulating MDM4
por: Lee, Kaping, et al.
Publicado: (2021)

Identification and characterization of critical genes associated with tamoxifen resistance in breast cancer
por: Zhang, Kai, et al.
Publicado: (2020)

Metronomic chemotherapy of cyclophosphamide plus methotrexate for advanced breast cancer: Real‐world data analyses and experience of one center
por: Lu, Qianyi, et al.
Publicado: (2020)

Local treatment for liver oligometastases in breast cancer patients: identification of prognostic factors and exploration of appropriate treatment strategy
por: Jiang, Kuikui, et al.
Publicado: (2020)

Administration of Lapatinib with Food Increases Its Plasma Concentration in Chinese Patients with Metastatic Breast Cancer: A Prospective Phase II Study
por: Xu, Fei, et al.
Publicado: (2020)

Miller–Payne Grading and 70-Gene Signature Are Associated With Prognosis of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early-Stage Breast Cancer After Neoadjuvant Chemotherapy
por: Wang, Liye, et al.
Publicado: (2021)

Construction and validation of a macrophage polarization-related prognostic index to predict the overall survival in patients with early-stage triple-negative breast cancer
por: Luo, Hanjia, et al.
Publicado: (2023)

Clinical value of circulating ESR1 mutations for patients with metastatic breast cancer: a meta-analysis
por: Zhang, Kai, et al.
Publicado: (2018)

Association of FOSL1 copy number alteration and triple negative breast tumors
por: Serino, Leandro Tamião Rodrigues, et al.
Publicado: (2019)

Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers
por: Lips, E H, et al.
Publicado: (2013)

The prognostic significance of skin involvement in breast cancer patients with chest wall recurrence
por: Zhou, Danyang, et al.
Publicado: (2023)

BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years
por: Robertson, L, et al.
Publicado: (2012)

Current Situation of Diagnosis and Treatment of HER2-Positive Metastatic Breast Cancer Patients in China: A Nationwide Cross-Sectional Survey of Doctors
por: Jiang, Kuikui, et al.
Publicado: (2023)

Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)
por: Schleiermacher, G, et al.
Publicado: (2011)

Genetic analysis of oligo-recurrence breast cancer: correlation with clinical outcomes
por: Jiang, Kuikui, et al.
Publicado: (2023)

Distribution Characteristics and Prognostic Value of Immune Infiltration in Oligometastatic Breast Cancer
por: Zhou, Danyang, et al.
Publicado: (2021)

Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification
por: Schleiermacher, G, et al.
Publicado: (2007)

Male Triple-Negative Breast Cancer
por: Qavi, Qasif, et al.
Publicado: (2021)

The BAG-1 cochaperone is a negative regulator of p73-dependent transcription
por: Wang, X-H, et al.
Publicado: (2009)

Immune Classification and Immune Landscape Analysis of Triple-Negative Breast Cancer
por: Hu, Shaojun, et al.
Publicado: (2021)

Reproductive outcomes of infertile couples undergoing assisted reproductive technology who are carriers of chromosomal abnormalities: a retrospective cohort study
por: Cui, Ling, et al.
Publicado: (2022)

Large miRNA survival analysis reveals a prognostic four-biomarker signature for triple negative breast cancer
por: Andrade, Fernando, et al.
Publicado: (2020)

Tumor mutational profile of triple negative breast cancer patients in Thailand revealed distinctive genetic alteration in chromatin remodeling gene
por: Niyomnaitham, Suvimol, et al.
Publicado: (2019)

MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma
por: Chen, H-C, et al.
Publicado: (2009)

Mutations primarily alter the inclusion of alternatively spliced exons
por: Baeza-Centurion, Pablo, et al.
Publicado: (2020)

Combined proteomics and transcriptomics identifies serpin family C member 1 associated protein as a biomarker of endometriosis
por: Li, Xiao-yan, et al.
Publicado: (2023)

Systematic analysis of copy number variants of uncertain significance partially overlapping with the haploinsufficient or triplosensitive genes in clinical testing
por: Zhou, Ran, et al.
Publicado: (2023)

Site-specific CpG methylation in the CCAAT/enhancer binding protein delta (CEBPδ) CpG island in breast cancer is associated with metastatic relapse
por: Palmieri, C, et al.
Publicado: (2012)

Balancing false positives and false negatives for the detection of differential expression in malignancies
por: De Smet, F, et al.
Publicado: (2004)

MYBL2 alternative splicing-related genetic variants reduce the risk of triple-negative breast cancer in the Chinese population
por: Chen, Xinyu, et al.
Publicado: (2023)

Reproductive outcomes in couples with sporadic miscarriage after embryonic chromosomal microarray analysis
por: Xia, Zhengyi, et al.
Publicado: (2023)

The Functional Impact of Alternative Splicing on the Survival Prognosis of Triple-Negative Breast Cancer
por: Wu, Sijia, et al.
Publicado: (2021)

Tumor stromal type is associated with stromal PD-L1 expression and predicts outcomes in breast cancer
por: Zhai, Qinglian, et al.
Publicado: (2019)

Genetic alterations in the coding region of the bak gene in uterine cervical carcinoma
por: Wani, K M Y, et al.
Publicado: (2003)

Alteration of the copy number and deletion of mitochondrial DNA in human hepatocellular carcinoma
por: Yin, P H, et al.
Publicado: (2004)

Molecular alterations associated with liver metastases development in colorectal cancer patients
por: Bruin, S C, et al.
Publicado: (2011)

Safety, tolerability, and pharmacokinetics of BAT8001 in patients with HER2‐positive breast cancer: An open‐label, dose‐escalation, phase I study
por: Hong, Ruoxi, et al.
Publicado: (2021)

Triple negative breast cancer: Immunogenicity, tumor microenvironment, and immunotherapy
por: Loizides, Sotiris, et al.
Publicado: (2023)

Non-genomic action of resveratrol on androgen and oestrogen receptors in prostate cancer: modulation of the phosphoinositide 3-kinase pathway
por: Benitez, D A, et al.
Publicado: (2007)

Genetic alterations in primary osteosarcoma from 54 children and adolescents by targeted allelotyping
por: Entz-Werle, N, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_vlbm36u91g4vl9a6nvk4la4t72